What is the research behind Lenire?
Lenire is the first device of its kind to receive FDA approval to treat tinnitus after a large-scale clinical trial. In the trial, 88.6% of patients recommended Lenire for tinnitus treatment. The trial’s results were consistent with confirmatory real-world evidence from 204* patients, and Lenire’s ground-breaking approach to tinnitus treatment had even been featured on Good Morning America and Washington Post. Watch the video and read the article below to learn more: